Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2024 | 04-2023 | 04-2022 | 04-2021 | 04-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,705,000 | 3,784,000 | 5,062,000 | 3,630,000 | 4,806,000 |
| Depreciation Amortization | 2,647,000 | 2,697,000 | 2,707,000 | 2,702,000 | 2,663,000 |
| Income taxes - deferred | -508,000 | -226,000 | -604,000 | -422,000 | -1,315,000 |
| Accounts receivable | -391,000 | -576,000 | -477,000 | -761,000 | 1,291,000 |
| Other Working Capital | -484,000 | -967,000 | -889,000 | -701,000 | 61,000 |
| Other Operating Activity | 1,818,000 | 1,327,000 | 1,547,000 | 1,792,000 | -272,000 |
| Operating Cash Flow | $6,787,000 | $6,039,000 | $7,346,000 | $6,240,000 | $7,234,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -307,000 | -171,000 | -190,000 | -463,000 | -1,465,000 |
| PPE Investments | -1,587,000 | -1,459,000 | -1,368,000 | -1,355,000 | -1,213,000 |
| Net Acquisitions | -211,000 | -1,867,000 | -91,000 | -994,000 | -488,000 |
| Other Investing Activity | -261,000 | 4,000 | -10,000 | -54,000 | -37,000 |
| Investing Cash Flow | $-2,366,000 | $-3,493,000 | $-1,659,000 | $-2,866,000 | $-3,203,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,073,000 | 2,284,000 | N/A | 2,478,000 | -17,000 |
| Debt Issued | N/A | 5,409,000 | N/A | 7,172,000 | 5,568,000 |
| Debt Repayment | N/A | -6,012,000 | -1,000 | -7,367,000 | -6,110,000 |
| Common Stock Issued | 284,000 | 308,000 | 429,000 | 474,000 | 662,000 |
| Common Stock Repurchased | -2,138,000 | -645,000 | -2,544,000 | -652,000 | -1,326,000 |
| Dividend Paid | -3,666,000 | -3,616,000 | -3,383,000 | -3,120,000 | -2,894,000 |
| Other Financing Activity | -3,000 | -2,688,000 | 163,000 | -3,121,000 | -81,000 |
| Financing Cash Flow | $-4,450,000 | $-4,960,000 | $-5,336,000 | $-4,136,000 | $-4,198,000 |
| Exchange Rate Effect | -230,000 | 243,000 | -231,000 | 215,000 | -86,000 |
| Beginning Cash Position | 1,543,000 | 3,714,000 | 3,593,000 | 4,140,000 | 4,393,000 |
| End Cash Position | 1,284,000 | 1,543,000 | 3,714,000 | 3,593,000 | 4,140,000 |
| Net Cash Flow | $-259,000 | $-2,171,000 | $121,000 | $-547,000 | $-253,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,787,000 | 6,039,000 | 7,346,000 | 6,240,000 | 7,234,000 |
| Capital Expenditure | -1,587,000 | -1,459,000 | -1,368,000 | -1,355,000 | -1,213,000 |
| Free Cash Flow | 5,200,000 | 4,580,000 | 5,978,000 | 4,885,000 | 6,021,000 |